NEW YORK (dpa-AFX Broker) - The US bank JPMorgan has raised its price target for Carl Zeiss Meditec from 59 to 70 euros ahead of the second quarter figures, but left the rating at "Underweight" due to the current share price level. Analyst Anchal Verma is cautious in a study published on Friday. According to the expert, sales are likely to have been under pressure in the second quarter of the financial year. At the same time, the company's annual outlook implies a significant upturn in the second half of the year. An end to the reduction in inventories on the customer side and price increases for certain products should help here. Nevertheless, he is concerned about the ongoing weakness in China and the consequences of the country's centralized procurement system. The price target increase reflects the takeover of D.O.R.C and the increased industry valuation./mis/nas

Publication of the original study: 04.04.2024 / 20:00 / BST

First dissemination of the original study: 05.04.2024 / 00:15 / BST

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------